Loading grant details…
Active
NON-SBIR/STTR RPGS
NIH (US)
Dual targeting of PI3K and NOS pathways in Metaplastic BreastCancer (MBC)
$6.12M
USD
| Funder | NATIONAL CANCER INSTITUTE |
|---|---|
| Recipient Organization | Methodist Hospital Research Institute |
| Country | United States |
| Start Date | Jul 08, 2023 |
| End Date | Jun 30, 2028 |
| Duration | 1,819 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10884885 |
Grant Description
ABSTRACT Metaplastic breast cancer (MpBC) is a rare subset accounting for
All Grantees
Methodist Hospital Research Institute
Advertisement
Advertisement
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Start Year
2023
End Year
2028
Grantees
1
Related Grants
AIDS Clinical Trials Group for Research on Therapeutics for...
NATIONAL INSTITUTE OF ALLERGY AND INFECT...
$762.2K USD
Leadership and Operations Center (LOC), AIDS Clinical Trials...
NATIONAL INSTITUTE OF ALLERGY AND INFECT...
$715K USD
Development of outpatient antiviral cocktails against SARS-C...
NATIONAL INSTITUTE OF ALLERGY AND INFECT...
$690.6K USD
Advertisement
